| For: | Al-Busafi SA, Alwassief A, Madian A, Atalla H, Alboraie M, Elbahrawy A, Eslam M. Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies. World J Hepatol 2025; 17(8): 108730 [PMID: 40901606 DOI: 10.4254/wjh.v17.i8.108730] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i8/108730.htm |
| Number | Citing Articles |
| 1 |
春漫 薛. Mechanisms, Epidemiology and Diagnostic Strategies of Metabolic Dysfunction-Associated Fatty Liver Disease. Journal of Clinical Personalized Medicine 2026; 5(02): 384 doi: 10.12677/jcpm.2026.52138
|
| 2 |
Said A. Al-Busafi, Mohammed Eslam. The AMAGE guidelines: Metabolic dysfunction-associated fatty liver disease through a regional lens. Annals of Hepatology 2026; 31(1): 102205 doi: 10.1016/j.aohep.2026.102205
|
